GURU.Markets stock price, segment price, and overall market index valuation
The company's share price SNES
SenesTech produces a unique product for rodent population control by reducing their birth rate. Its stock price is a bet on the commercialization of this innovative approach. The chart reflects the product's slow adoption and the need for ongoing funding.
Share prices of companies in the market segment - Safety
SenesTech is a biotech company that has developed a unique liquid contraceptive for controlling rat and other rodent populations. We've rated it "Safety." The chart below shows how investors rate innovative and humane pest control methods.
Broad Market Index - GURU.Markets
SenesTech is a biotech company that developed the world's first contraceptive for rat control. Its unique approach to pest control makes it a component of the GURU.Markets index. The chart below compares its performance with the market.
Change in the price of a company, segment, and market as a whole per day
SNES - Daily change in the company's share price SNES
For SenesTech, Inc., a developer of rodent birth control products, daily volatility reflects sensitivity to the commercial success of its products. This metric is an indicator of demand from the agricultural and municipal sectors.
Daily change in the price of a set of shares in a market segment - Safety
SenesTech, Inc. is a biotechnology company. This chart highlights the sector's high volatility. Comparing it to SNES, which focuses on rodent population control, helps us understand its unique, niche demand.
Daily change in the price of a broad market stock, index - GURU.Markets
SenesTech has developed a technology for rodent population control through birth control. The stock price of this unique biotech company reflects the demand for humane and effective pest control methods. Its dynamics contribute to the overall market picture.
Dynamics of market capitalization of the company, segment and the market as a whole over 12 months
Annual dynamics of the company's market capitalization SNES
SenesTech, Inc.'s year-over-year performance is a story of commercializing its rodent control technology. Its 12-month market cap growth reflects its success in selling its ContraPest product, which reduces rat births and offers a humane and environmentally friendly alternative to traditional poisons.
Annual dynamics of market capitalization of the market segment - Safety
SenesTech, Inc. is developing a unique rodent birth control technology as a humane alternative to poison. Its stock price is extremely volatile, reflecting investors' faith in its breakthrough potential and ability to commercialize its unique technology.
Annual dynamics of market capitalization of broad market stocks, index - GURU.Markets
SenesTech, with its rodent birth control technology, is a niche agribusiness. Its stock price isn't tied to the economy, but rather to its success in commercializing this unique product. The chart is a speculative story of how innovation struggles to find its way in a conservative market.
Dynamics of market capitalization of the company, segment and the market as a whole for the month
Monthly dynamics of the company's market capitalization SNES
SenesTech develops technologies for rodent population control. Its monthly growth depends on the progress of commercializing its products. News of contracts with municipalities and large agricultural holdings are the main drivers of its growth.
Monthly dynamics of market capitalization of the market segment - Safety
This chart reflects the dynamics of the biotech sector. For SenesTech, with its unique niche in rodent fertility control, it's the backdrop. Its movements illustrate how the introduction of its innovative, yet difficult-to-sell, product is impacting its commercial success.
Monthly dynamics of market capitalization of broad market stocks, index - GURU.Markets
SenesTech has developed and commercialized a liquid bait that induces infertility in rodents, offering a humane method of population control. This is a unique niche technology. The full market chart helps assess how SenesTech's stock, as a biotech company, is influenced by its own sales and contract news, rather than by overall market sentiment.
Dynamics of market capitalization of the company, segment and the market as a whole for the week
Weekly dynamics of the company's market capitalization SNES
SenesTech, the developer of a unique chemical sterilization technology for rodent control, is responding to business news. Its weekly share price performance reflects contracts with municipalities, agricultural companies, and other major clients, confirming demand for its innovative approach.
Weekly dynamics of market capitalization of the market segment - Safety
SenesTech, like other biotech companies, is dependent on overall investor sentiment. However, its unique niche (rodent population control) makes it less dependent on pharmaceutical industry news. The chart allows you to compare its performance with the broader biotech sector and highlight this difference.
Weekly dynamics of market capitalization of stocks of the broad market, index - GURU.Markets
As a biotech company, SenesTech often ignores general market trends. Its fate depends not on GDP or inflation, but on the commercial success of its products. The chart below clearly demonstrates how SNES stock can live its own life, separate from the broader market.
Market capitalization of the company, segment and market as a whole
SNES - Market capitalization of the company SNES
SenesTech's chart is a unique bet on rodent population control. The company develops "contraceptives" for rats to reduce their numbers humanely. Its market cap reflects how investors view this innovative, yet not yet widely adopted, technology.
SNES - Share of the company's market capitalization SNES within the market segment - Safety
SenesTech has developed a non-lethal yet effective method for rodent control that induces infertility. Its market share in the pest control sector is based on this unique and humane technology. The chart shows the demand for its product, ContraPest, as an environmentally friendly alternative to poisons.
Market capitalization of the market segment - Safety
SenesTech has developed a non-lethal method for rodent population control that limits their birth rate. The graph below shows the market capitalization of the security and sanitation sector. This represents an assessment of this innovative and humane approach to solving the perennial problem of pest control.
Market capitalization of all companies included in a broad market index - GURU.Markets
SenesTech has developed a non-lethal method for rodent control that reduces their birth rate. Its capitalization is based on a humane and environmentally friendly approach to pest control. The chart below shows the economic weight of companies offering new solutions in this field.
Book value capitalization of the company, segment and market as a whole
SNES - Book value capitalization of the company SNES
SenesTech is based on a unique biotechnology. The company's book value reflects its patents and production capacity for ContraPest, a rat "contraceptive" that humanely controls their population. The chart below shows how the company is building the material base for commercializing its innovative approach to pest control.
SNES - Share of the company's book capitalization SNES within the market segment - Safety
SenesTech, Inc. manufactures rodent control products at its own facility. This production line is its unique tangible asset. The S_BCap_Seg graph shows its share of the niche infrastructure in the biotech security sector.
Market segment balance sheet capitalization - Safety
SenesTech has developed a technology for rodent fertility control. Its business requires manufacturing facilities to produce this chemical. The chart below shows how investments in specialized production form the foundation of its unique business model.
Book value of all companies included in the broad market index - GURU.Markets
SenesTech's book value is a scientific platform for rodent population control. The company's assets include its production facilities for the liquid bait ContraPest®, which induces infertility in rats. This represents capital invested in the development of a humane and environmentally friendly method of pest control.
The ratio of market capitalization to book capitalization of a company, segment, and the market as a whole
Market capitalization to book capitalization ratio - SNES
SenesTech has developed a non-lethal method for rodent population control that reduces their reproductive rate. The company's book value is low. Its market capitalization reflects its unique and environmentally friendly technology, patents, and the potential for commercialization of this innovative approach to pest control.
Market to book capitalization ratio in a market segment - Safety
SenesTech has developed a non-lethal method for rodent population control that reduces their birth rate. The company's value lies in its unique and environmentally friendly product. The graph shows the market premium for this innovation compared to its production and research assets.
Market to book capitalization ratio for the market as a whole
SenesTech has developed a technology for controlling rodent populations by limiting their birthrates. The company's value lies in its unique and patented approach to solving an age-old problem. The chart shows how the market is valuing this innovative technology, which has the potential to transform the multi-billion-dollar pest control industry.
Debts of the company, segment and market as a whole
SNES - Company debts SNES
SenesTech, a company developing rodent fertility control technology, is using debt to commercialize its product. This chart shows how the company is funding the production, marketing, and sales of its innovative solution for municipalities and agribusinesses. This investment is aimed at bringing this new, environmentally friendly technology to market.
Market segment debts - Safety
SenesTech has developed an innovative technology for rodent population control through birth control rather than poison. Commercializing such a unique product requires time and investment in marketing and consumer education. This chart shows the company's financial position as it moves toward widespread market adoption.
Market debt in general
Debt to book value of the company, segment and market as a whole
The company's debt to book capitalization ratio SNES
SenesTech has developed a technology for controlling rodent populations through birth control. This chart shows the company's reliance on debt. For a biotech company with a unique but niche product, debt may be necessary for production and marketing. This is an indicator of confidence in the commercialization of the technology.
Market segment debt to market segment book capitalization - Safety
SenesTech develops technologies to control rodent populations through birth control. This chart for the biotech and security sector shows how companies finance the commercialization of their unique scientific developments. This allows us to assess how well a company's financial strategy aligns with its niche market.
Debt to book value of all companies in the market
SenesTech has developed a non-lethal method for rodent control that induces infertility. The company's product is targeted at agriculture and municipal services. The market's debt-to-book ratio chart reveals the overall economic situation, which influences potential clients' budgets and their willingness to invest in new pest control technologies.
P/E of the company, segment and market as a whole
P/E - SNES
SenesTech has developed a non-lethal method for rodent control that induces infertility. This graph demonstrates the potential for humane and environmentally friendly pest control. Its value demonstrates the investors' confidence in the adoption of this innovative approach by cities and agricultural companies as an alternative to traditional poisons.
P/E of the market segment - Safety
SenesTech represents the pest control biotechnology sector. This chart shows the average P/E for the chemical or biotech industry. Comparing a company's P/E to this benchmark helps understand the premium investors are willing to pay for its innovative and environmentally friendly approach compared to traditional pesticide manufacturers.
P/E of the market as a whole
SenesTech has developed ContraPest, a non-lethal method for rodent control that induces infertility. It is an environmentally friendly alternative to poisons. This graph reflects global environmental trends. The company's valuation depends on the commercial success of this innovative product and its acceptance in a market that traditionally relies on rodenticides.
Future P/E of the company, segment and market as a whole
Future (projected) P/E of the company SNES
SenesTech has developed a non-lethal method for rodent population control using a bait that reduces their fertility. The graph shows future revenue expectations, which depend on commercial acceptance of this innovative yet unconventional approach. Analysts are assessing whether sales can grow to a profit-making level.
%20P%2FE%20SNES&width=1500&height=450&colorIndex=35&filename=GURU_Markets_-_Chart-of-the-companys-future-projected-PE-SNES&v=1772517633707 "Chart of the company's future (projected) P/E SNES")
Future (projected) P/E of the market segment - Safety
SenesTech has developed a non-lethal method for rodent control that induces infertility. This chart shows how its future revenue expectations compare to the industry average. Does the market believe its eco-friendly and humane approach will become a viable alternative to traditional poisons?
%20P%2FE%20graph%20of%20the%20market%20segment%20-%20Safety&width=1500&height=450&colorIndex=36&filename=GURU_Markets_-_Future-projected-PE-graph-of-the-market-segment-Safety&v=1772517633715 "Future (projected) P/E graph of the market segment - Safety")
Future (projected) P/E of the market as a whole
SenesTech has developed and commercialized ContraPest, a liquid bait that induces infertility in rats. It's an innovative approach to pest control. The company's success depends on the adoption of its product by municipalities and businesses, not on general economic cycles.
%20P%2FE%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=37&filename=GURU_Markets_-_Chart-of-the-future-projected-PE-of-the-market-as-a-whole&v=1772517633726 "Chart of the future (projected) P/E of the market as a whole")
Profit of the company, segment and market as a whole
Company profit SNES
SenesTech, Inc. has developed and commercialized a rodent birth control technology, offering a humane alternative to poison. The company's profits depend on the adoption of its product in agriculture, cities, and commercial settings. This chart shows how demand for environmentally friendly pest control methods impacts the innovative company's financial performance.
Profit of companies in the market segment - Safety
SenesTech, Inc. has developed and commercialized a rodent birth control technology as a humane alternative to poison. This chart shows the overall profitability of the security sector. The company's unique product targets the vast pest control market. Its commercial success will depend on the adoption of this innovative technology by agriculture and cities.
Overall market profit
SenesTech, Inc. has developed and markets a liquid bait that induces rodent infertility, offering a humane method of population control. Demand for its product depends on municipalities and businesses recognizing its effectiveness. This chart illustrates the general economic cycles within which SenesTech is addressing a specific and important environmental problem.
Future (predicted) profit of the company, segment and market as a whole
Future (projected) profit of the company SNES
SenesTech has developed a non-lethal method for rodent control that induces infertility. Future revenue projections presented here depend on the commercial acceptance of this innovative approach compared to traditional poisons. This chart shows analysts' expectations regarding demand for more humane and environmentally friendly pest control solutions.
%20profit%20of%20the%20company%20SNES&width=1500&height=450&colorIndex=41&filename=GURU_Markets_-_Graph-of-future-projected-profit-of-the-company-SNES&v=1772517633777 "Graph of future (projected) profit of the company SNES")
Future (predicted) profit of companies in the market segment - Safety
SenesTech, Inc. has developed and commercialized technology for managing rodent populations by reducing their reproductive rate. This chart shows profitability forecasts for the safety and hygiene sector. It reflects expected demand for humane and environmentally friendly pest control methods.
%20profits%20of%20companies%20in%20a%20market%20segment%20-%20Safety&width=1500&height=450&colorIndex=42&filename=GURU_Markets_-_Graph-of-future-predicted-profits-of-companies-in-a-market-segment-Safety&v=1772517633788 "Graph of future (predicted) profits of companies in a market segment - Safety")
Future (predicted) profit of the market as a whole
SenesTech develops rodent control technologies. Demand for their products from agriculture and municipalities may be affected by budget constraints. A forecast decline in overall market profits could lead to budget cuts for such programs, while economic growth facilitates investment in new technologies.
%20profits%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=43&filename=GURU_Markets_-_Chart-of-future-predicted-profits-of-the-market-as-a-whole&v=1772517633793 "Chart of future (predicted) profits of the market as a whole")
P/S of the company, segment and market as a whole
P/S - SNES
SenesTech, Inc. has developed a technology for rodent population control through birth control. Revenue is driven by adoption of its product in agriculture and urban areas. The P/S ratio reflects investor sentiment regarding this innovative and environmentally friendly approach to pest control and its commercial potential.
P/S market segment - Safety
SenesTech, Inc. has developed and commercialized a technology for controlling rodent populations by limiting their reproductive capacity. It is an environmentally friendly alternative to poisons. This chart shows how the market views their innovative approach to pest control and the commercialization potential of their unique product compared to traditional methods.
P/S of the market as a whole
SenesTech has developed a technology for controlling rodent populations by limiting their birthrates. The company's revenue depends on the implementation of this environmentally friendly pest control method. This chart illustrates the average revenue estimate, which helps understand how the market values the earnings of a company with an innovative but niche product.
Future P/S of the company, segment and market as a whole
Future (projected) P/S of the company SNES
SenesTech has developed a non-lethal yet effective method for controlling rodent populations by reducing their birth rate. It is an environmentally friendly alternative to poisons. This chart shows investor expectations for future revenue from sales of this innovative product, betting on a shift in the pest control market toward more humane solutions.
%20P%2FS%20SNES&width=1500&height=450&colorIndex=47&filename=GURU_Markets_-_The-graph-of-the-companys-future-projected-PS-SNES&v=1772517633817 "The graph of the company's future (projected) P/S SNES")
Future (projected) P/S of the market segment - Safety
SenesTech, Inc. has developed and commercialized a rodent control technology, offering a humane way to manage pest populations. This chart shows how the market estimates future sales of its unique product, ContraPest. It compares it to other companies in the security and pest control sector, reflecting its innovative approach.
%20P%2FS%20market%20segment%20graph%20-%20Safety&width=1500&height=450&colorIndex=48&filename=GURU_Markets_-_Future-projected-PS-market-segment-graph-Safety&v=1772517633825 "Future (projected) P/S market segment graph - Safety")
Future (projected) P/S of the market as a whole
SenesTech has developed a non-lethal method for rodent control that renders them infertile. It's an innovative and environmentally friendly approach to pest control. This graph reflects general sales expectations, and SNES illustrates how scientific advances in biotechnology can be applied in the most unexpected areas.
%20P%2FS%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=49&filename=GURU_Markets_-_Chart-of-the-future-projected-PS-of-the-market-as-a-whole&v=1772517633829 "Chart of the future (projected) P/S of the market as a whole")
Sales of the company, segment and market as a whole
Company sales SNES
SenesTech, Inc. has developed and commercialized an innovative solution for rodent population control through birth control. This chart shows revenue from sales of its liquid bait, ContraPest®, which renders rats infertile. Demand for the product is driven by the search for more humane and effective pest control methods.
Sales of companies in the market segment - Safety
SenesTech has developed and commercialized a technology for controlling rodent populations by limiting their birthrates. This graph shows the revenue from sales of its ContraPest product. It allows investors to track the success of this innovative and humane method in the marketplace.
Overall market sales
SenesTech, Inc. develops technology to control rodent populations by limiting their reproductive capacity. Demand for its products comes from agriculture, municipalities, and commercial enterprises. This general economic activity impacts its clients' budgets, but the need for pest control is constant.
Future sales volume of the company, segment and market as a whole
Future (projected) sales of the company SNES
SenesTech has developed a non-lethal method for rodent control by inducing infertility. The company's revenue forecast depends on the commercialization of its product and its adoption in agriculture and urban areas. This chart shows analysts' estimates of demand for humane and environmentally friendly pest control solutions.
%20sales%20of%20the%20company%20SNES&width=1500&height=450&colorIndex=53&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-the-company-SNES&v=1772517633859 "Schedule of future (projected) sales of the company SNES")
Future (projected) sales of companies in the market segment - Safety
SenesTech has developed a non-lethal method for controlling rodent populations that reduces their reproductive capacity. This graph shows projected revenues for the entire security and sanitation sector. It helps estimate the demand for humane and environmentally friendly pest control solutions, a key market niche for SenesTech.
%20sales%20of%20companies%20in%20the%20market%20segment%20-%20Safety&width=1500&height=450&colorIndex=54&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-companies-in-the-market-segment-Safety&v=1772517633871 "Schedule of future (projected) sales of companies in the market segment - Safety")
Future (projected) sales of the market as a whole
SenesTech has developed a non-lethal method for rodent control that reduces their fertility. Demand for its ContraPest product depends on the pest control budgets of municipalities, agricultural enterprises, and commercial facilities. This business activity expectation chart reflects their willingness to invest in innovative and environmentally friendly pest control solutions.
%20sales%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=55&filename=GURU_Markets_-_Schedule-of-future-predicted-sales-of-the-market-as-a-whole&v=1772517633884 "Schedule of future (predicted) sales of the market as a whole")
Marginality of the company, segment and market as a whole
Company marginality SNES
SenesTech has developed and is commercializing a rodent birth control product as an alternative to poison. This graph shows the path to profitability for this innovative product. The company's ability to generate profit depends on the widespread adoption of its technology by municipalities and businesses.
Market segment marginality - Safety
SenesTech developed and commercialized the world's first rodent control technology, offering a humane alternative to poison. This chart shows the average profitability in the agricultural and defense biotechnology sector. It helps assess how profitable SenesTech's unique and patented product could be in this market.
Market marginality as a whole
SenesTech, Inc. has developed a rodent birth control technology for pest control. It's an innovative and environmentally friendly approach to an age-old problem. This profitability chart doesn't reflect the company's potential, which depends on market acceptance and proof of its cost-effectiveness compared to traditional pesticides.
Employees in the company, segment and market as a whole
Number of employees in the company SNES
SenesTech has developed and commercialized a rodent fertility control technology as an alternative to poison. Its small team includes scientists, production specialists, and sales specialists. This chart shows how a niche biotech company brings an innovative and eco-friendly product to market.
Share of the company's employees SNES within the market segment - Safety
SenesTech, Inc. has developed and commercialized a population control technology for rodent population control. This chart illustrates its unique and environmentally friendly approach to solving an age-old problem. It reflects the number of biologists, chemists, and pest control specialists working on a humane and effective method of population control that SenesTech brings together.
Number of employees in the market segment - Safety
SenesTech, Inc. has developed a population control technology for rodent population management. This chart shows employment in the security and pest control sector. Growth in this field reflects the need for more humane and environmentally friendly methods of population control, creating a niche market for SenesTech's innovative products.
Number of employees in the market as a whole
SenesTech, Inc. has developed a technology for controlling rodent populations by limiting their reproductive capacity. This is an innovative approach to solving an age-old problem. This graph shows the overall employment picture, where biotech companies operating in niche but important fields also contribute to the development of a knowledge-intensive economy.
Market capitalization per employee (in thousands of dollars) of the company, segment, and market as a whole
Market capitalization per employee (in thousands of dollars) of the company SNES (SNES)
SenesTech, Inc. develops animal population control technologies. This is a unique niche at the intersection of biotechnology and ecology. This chart shows how the market values this specialized intellectual capital. The high cost per employee speaks to the value of their scientific research and the potential to solve a global problem.
%20of%20the%20company%20SNES%20(SNES)&width=1500&height=450&colorIndex=63&filename=GURU_Markets_-_Chart-of-market-capitalization-per-employee-in-thousands-of-dollars-of-the-company-SNES-SNES&v=1772517633918 "Chart of market capitalization per employee (in thousands of dollars) of the company SNES (SNES)")
Market capitalization per employee (in thousands of dollars) in the market segment - Safety
SenesTech has developed a unique technology for rodent population control through birth control. The market value per employee reflects the value of this innovative and environmentally friendly alternative to poisons. A comparison with traditional pest control companies demonstrates the market's confidence in the potential of its scientific approach.
%20by%20market%20segment%20-%20Safety&width=1500&height=450&colorIndex=64&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-by-market-segment-Safety&v=1772517633923 "Market capitalization per employee (in thousands of dollars) by market segment - Safety")
Market capitalization per employee (in thousands of dollars) for the overall market
SenesTech has developed and commercialized a product for rodent birth control, offering a humane method of pest control. This is a unique scientific approach. This chart shows how the market perceives the potential of this innovative technology and the team's ability to convince the market of its effectiveness.
%20for%20the%20overall%20market&width=1500&height=450&colorIndex=65&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-for-the-overall-market&v=1772517633930 "Market capitalization per employee (in thousands of dollars) for the overall market")
Profit per employee (in thousands of dollars) for the company, segment, and market as a whole
Profit per employee (in thousands of dollars) of the company SNES (SNES)
SenesTech is a biotech company that has developed a unique product: a "rat contraceptive" (ContraPest) for rodent population control. This is the R&D and commercialization phase. This graph shows how successfully the company is selling this innovative, yet niche, solution, and whether sales cover R&D and personnel costs.
%20Chart%20SNES%20(SNES)&width=1500&height=450&colorIndex=66&filename=GURU_Markets_-_Company-Profit-Per-Employee-in-thousands-of-dollars-Chart-SNES-SNES&v=1772517633932 "Company Profit Per Employee (in thousands of dollars) Chart SNES (SNES)")
Profit per employee (in thousands of dollars) in the market segment - Safety
SenesTech has developed and commercialized a technology for managing rodent populations through birth control. This graph demonstrates the commercial potential of their unique scientific approach. It reflects how effectively the company can monetize its innovative and environmentally friendly alternative to traditional poisons, a key indicator of its competitiveness.
%20in%20the%20market%20segment%20-%20Safety&width=1500&height=450&colorIndex=67&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-in-the-market-segment-Safety&v=1772517633945 "Chart of profit per employee (in thousands of dollars) in the market segment - Safety")
Profit per employee (in thousands of dollars) for the market as a whole
SenesTech, Inc. develops and markets rodent control technologies (rat contraceptives). It is a unique biotech pest control product. This chart shows how successfully the company is commercializing its innovative product. It reflects the balance between production costs, R&D, and sales team effectiveness.
%20for%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=68&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-for-the-market-as-a-whole&v=1772517633956 "Chart of profit per employee (in thousands of dollars) for the market as a whole")
Sales to employees of the company, segment and market as a whole
Sales per company employee SNES (SNES)
SenesTech, Inc. is developing rodent control technology. This graph reflects the commercialization process of this science-intensive product. Increased revenue per employee will indicate successful implementation of its solution in agriculture and cities, as well as recognition of its effectiveness compared to traditional methods.
&width=1500&height=450&colorIndex=69&filename=GURU_Markets_-_Sales-chart-per-company-employee-SNES-SNES&v=1772517633964 "Sales chart per company employee SNES (SNES)")
Sales per employee in the market segment - Safety
SenesTech (SNES) is the developer of ContraPest, a liquid bait that induces infertility in rats, offering a humane method of population control. This chart shows the average revenue per employee in the segment. Comparing SNES to this benchmark demonstrates how effectively their team is commercializing this innovative, yet niche, product compared to traditional poison manufacturers.
Sales per employee for the market as a whole
SenesTech (SNES) is a biotech company that has developed a liquid "contraception" for rodent control. It's a unique niche product and is in the early stages of commercialization. This metric demonstrates how successful their sales team is in convincing clients (farms and cities) to use their innovative, albeit expensive, population control method.
Short shares by company, segment and market as a whole
Shares shorted by company SNES (SNES)
SenesTech is the company that developed ContraPest, a non-toxic method for controlling rodent populations. This chart shows that investors are skeptical of its commercial success. The bears are betting that this product is too expensive and difficult to use compared to traditional poisons, and that the company will never become profitable.
&width=1500&height=450&colorIndex=72&filename=GURU_Markets_-_Short-Shares-Chart-for-the-Company-SNES-SNES&v=1772517633995 "Short Shares Chart for the Company SNES (SNES)")
Shares shorted by market segment - Safety
SenesTech (SNES) is a unique company selling rat "contraceptives" (ContraPest) for humane population control. This chart highlights the pessimism in the sector. The surge in short positions in the industry is a bet that this technology is a commercial failure. Investors doubt that cities and businesses will choose this expensive and slow method of "birth control" over cheap and quick poisons.
Shares shorted by the overall market
SenesTech offers an innovative R&D product—birth control for rodents. It's not a "must-have" service. When this fear indicator rises, investors anticipate a recession. They fear that clients (cities, farmers) will freeze budgets for "unnecessary" innovations, preferring old, cheap methods.
RSI 14 indicator for a company, segment, and market as a whole
The company's RSI 14 indicator SNES (SNES)
SenesTech offers a unique product – a rodent birth control technology for pest control. It's a niche business, and the market is trying to assess its potential. This indicator reflects investor sentiment: it warms up on news of major contracts or approvals and cools when the focus shifts to the slow pace of technology adoption.
&width=1500&height=450&colorIndex=75&filename=GURU_Markets_-_RSI-14-indicator-chart-for-the-companys-stock-SNES-SNES&v=1772517634005 "RSI 14 indicator chart for the company's stock SNES (SNES)")
RSI 14 Market Segment - Safety
SenesTech is an innovator in pest control. Instead of poisons, they offer ContraPest, a rodent "contraceptive" that controls populations by reducing birth rates. It's a science-based approach to hygiene. This chart shows the general sentiment in the security and control services sector. It helps assess how the market views this industry and whether SenesTech's unique technology stands out from the crowd.
RSI 14 for the overall market
SenesTech (SNES) is a "green" R&D company. This chart is its lifeline. During periods of market euphoria, investors are willing to generously fund unprofitable but hyped projects. In moments of panic, the money supply is turned off, and investors demand profits rather than promises, threatening SNES's survival.
Analyst consensus forecast for the company's share price, the segment, and the market as a whole
Analyst consensus stock price forecast SNES (SNES)
SenesTech is the company behind ContraPest, a "rat contraceptive." It's a liquid bait that induces infertility in rodents, offering a humane method of population control. This chart shows the speculative average 12-month price target from analysts, based on their belief in the commercialization of this product.
&width=1500&height=450&colorIndex=78&filename=GURU_Markets_-_A-chart-showing-analyst-consensus-forecasts-for-the-expected-stock-price.-SNES-SNES&v=1772517634030 "A chart showing analyst consensus forecasts for the expected stock price. SNES (SNES)")
The difference between the consensus estimate and the actual stock price SNES (SNES)
SenesTech isn't poison, but a "rat contraceptive." The company produces ContraPest, a bait that solves the rodent problem by inducing infertility. This chart shows the analysts' forecast for the stock's upside or downside. It measures the gap between the price and forecast, reflecting their faith in this unique technology.
&width=1500&height=450&colorIndex=79&filename=GURU_Markets_-_A-chart-showing-the-difference-between-the-consensus-forecast-and-the-actual-stock-price.-SNES-SNES&v=1772517634039 "A chart showing the difference between the consensus forecast and the actual stock price. SNES (SNES)")
Analyst consensus forecast for stock prices by market segment - Safety
SenesTech is a biotech company that developed "rat contraceptive" (ContraPest), an eco-friendly alternative to poisons. This chart shows the general expectations of analysts in the security (and chemical) sector. It reflects whether experts believe in the commercial success of this innovative, yet niche, pest control technology.
Analysts' consensus forecast for the overall market share price
SenesTech is a unique "biotech" company solving the problem of... rats. They've developed a "contraceptive" for rodents (ContraPest) that reduces their population. This chart shows overall market sentiment. For SenesTech, a company with an innovative but difficult-to-sell product, the overall optimism is important because it reflects the willingness of municipalities and businesses to invest in new pest control methods.
AKIMA index of the company, segment and market as a whole
AKiMA Company Index SNES
SenesTech is a humane pest control company. Their signature product is ContraPest, a liquid birth control for rats. Instead of killing them, their product renders rat populations infertile. This chart summarizes their implementation history. It reflects their (very slow) path to commercialization and their success in convincing cities and farms to embrace this green approach.
AKIMA Market Segment Index - Safety
SenesTech (SNES) is a biotech company solving the rodent problem. They have developed ContraPest, a liquid rat contraceptive that reduces their population in a humane and environmentally friendly manner. The chart shows the average index for the segment, helping investors assess the demand for this unique pest control technology compared to the average.
The AKIM Index for the overall market
SenesTech is a biotech company that produces ContraPest, a rat population control product that reduces fertility. This chart, which reflects the market average, is a backdrop. It helps assess how this unique, yet commercially challenging, "green" technology stacks up against the backdrop of overall macroeconomic fluctuations.
